Solu Therapeutics Debuts with $31 Million in Seed Funding to Unlock Antibody-Intractable Cell Surface Targets Solu Therapeutics
Top Sustainability VCs Lead $US28 Million Series B for Australian Breakthrough Mining Tech Plotlogic Plotlogic
NASA Selects Zeno to Lead Team to Develop Radioisotope Power System for Lunar Applications Zeno Power
Climate Breakthrough: Brimstone’s Decarbonized Portland Cement First to Meet Essential Building Industry Standard, Unlocking the Potential of Net-Zero Construction Brimstone
Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery Recursion Pharmaceuticals
Twelve Commences Construction of First Commercial-Scale Plant in US for Producing Sustainable Aviation Fuel from CO2 Twelve
Oklo, an Advanced Fission Technology Company, to Go Public via Merger with AltC Acquisition Corp. Oklo
Databricks Signs Definitive Agreement to Acquire MosaicML, a Leading Generative AI Platform Databricks MosaicML
Kanvas Biosciences Announces $12 Million Pre-Series A to Accelerate Microbiome Drug Development Kanvas Biosciences
Nium raises funds to replace Haber-Bosch, the most polluting chemical industrial process on Earth Nium
Demox Labs Launches Leo Wallet and Raises $4.5 Million To Build Zero Knowledge Proof Blockchain Infrastructure Demox Labs
Twelve and Etihad Airways partner to advance sustainable aviation fuel made from CO2 and renewable energy Twelve
LiveEO and Capella Space Partner to bring High-Speed, High-Resolution SAR Satellite Insights to Asset Managers Capella Space
MosaicML Launches Inference API and Foundation Series for Generative AI; Leading Open Source GPT Models, Enterprise-Grade Privacy and 15x Cost Savings MosaicML
Gene & cell therapy manufacturing specialist Ascend launches with over $130M of funding as expert teams merge Ascend
First Light Field-Enabled Spine Surgery Navigation Platform, Proprio Paradigm™, Receives FDA Clearance Proprio
Totus Medicines Announces First Patient Dosed in Phase 1 Trial of TOS-358 for the Treatment Of Select Solid Tumors Totus Medicines